How did KRMD's recent EPS compare to expectations?
The most recent EPS for KORU Medical Systems Inc is $-0.01, expectations of $.
How did KORU Medical Systems Inc KRMD's revenue perform in the last quarter?
KORU Medical Systems Inc revenue for the last quarter is $-0.01
What is the revenue estimate for KORU Medical Systems Inc?
According to 7 of Wall street analyst, the revenue estimate of KORU Medical Systems Inc range from $12.62M to $11.27M
What's the earning quality score for KORU Medical Systems Inc?
KORU Medical Systems Inc has a earning quality score of B+/55.332573. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does KORU Medical Systems Inc report earnings?
KORU Medical Systems Inc next earnings report is expected in 2026-06-10
What are KORU Medical Systems Inc's expected earnings?
KORU Medical Systems Inc expected earnings is $, according to wall-street analysts.
Did KORU Medical Systems Inc beat earnings expectations?
KORU Medical Systems Inc recent earnings of $10.9M expectations.
Key Stats
Prev.Close
$4.25
Open
$4.39
Day's Range
$4.24 - $4.43
52 week range
$1.86 - $6.6
Volume
128.9K
Avg.Volume
191.7K
Dividend yield
--
EPS (TTM)
-0.06
Market Cap
$200.3M
What is KRMD?
KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. The company is headquartered in Mahwah, New Jersey and currently employs 73 full-time employees. The firm is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The firm is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.